Return to Faculty Listing
Benjamin Lopman
Professor
Faculty, Epidemiology
Jointly Appointed, Environmental Health
I am an infectious disease epidemiologist, with a research focus on vaccines and enteric viruses. My team conducts both global and domestic research mainly targeted at diarrheal diseases caused by rotavirus and norovirus. We employ a range of approaches including field studies, statistical analysis and dynamic mathematical modeling to address policy-relevant public health research questions.
Since Spring 2020, we have worked extensively on the epidemiology of the COVID-19 pandemic.
For a full list of publications see PubMed or my Google Scholar profile.
Update Profile
Areas of Interest
- Clinical Trials
- Genetic Epidemiology
- Global Health
- Infectious Disease
- Modeling
- Surveillance
- Vaccines
Education
- BS, Microbiology and Cell Science 1999, University of Florida
- MSc, Medical Demography 2000, London School of Hygiene and Tropical Medicine
- PhD 2005, Open University/Health Protection Agency
Courses Taught
- EPI 569: Concepts & Methods in ID EPI
- EPI 798R: Pre-candidacy Research
- EPI 799R: Research
Publications
- PubMed, 2021, Full Publication List , , ,
- Max S Y Lau, Bryan Grenfell, Michael Thomas, Michael Bryan, Kristin Nelson, Ben Lopman, 2020, Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA, PNAS, ,
- Molly E Gallagher, Andrew J Sieben, Kristin N Nelson, Alicia N M Kraay, Walter A Orenstein, Ben Lopman, Andreas Handel, Katia Koelle, 2020, Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates, Nature Medicine, ,
- Carly Adams, David Young, Paul A Gastañaduy, Prabasaj Paul, Zach Marsh , Aron J Hall, Benjamin A Lopman, 2020, Quantifying the roles of vomiting, diarrhea, and residents vs. staff in norovirus transmission in U.S. nursing home outbreaks, PLOS Computation Biology, ,
- Julia M Baker, Jacqueline E Tate, Juan Leon, Michael J Haber, Benjamin A Lopman, 2019, Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries, PLOS Medicine, ,
- Lopman BA, Steele D, Kirkwood CD, Parashar UD, 2016, The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control, PLoS Med, ,
- Lopman B, Simmons K, Gambhir M, Vinjé J, Parashar U, 2014, Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus, Am J Epidemiol, ,
- Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA, 2014, Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis, Lancet Infect Dis, ,
- Gastañaduy PA, Curns AT, Parashar UD, Lopman BA, 2013, Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination, JAMA, ,
- Trivedi TK, DeSalvo T, Lee L, Palumbo A, Moll M, Curns A, Hall AJ, Patel M, Parashar UD, Lopman BA, 2012, Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010, JAMA, ,
- Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torvén M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szücs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M., 2004, Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant, Lancet, ,